Evidence map›Paper›PMID 36421483›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Gold Nanoparticles Supported on Ceria Nanoparticles Modulate Leukocyte-Endothelium Cell Interactions and Inflammation in Type 2 Diabetes.

Pedro Díaz-Pozo, Francisco Canet, Abdessamad Grirrane, Sandra Lopez-Domenech, José Raul Herance, Nadezda Apostolova, Clara Luna-Marco, Susana Rovira-Llopis, Miguel Marti, Carlos Morillas and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Pedro Díaz-PozoService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0001-5241-5994
Francisco CanetService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0002-6626-2762
Abdessamad GrirraneInstituto Universitario de Tecnología Química CSIC-UPV, Universidad Politécnica de Valencia, Avenida de los Naranjos s/n, 46022 Valencia, Spain.ORCID 0000-0001-5388-3554
Sandra Lopez-DomenechService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0003-2067-9308
José Raul HeranceMedical Molecular Imaging Research Group, Vall d'Hebron Research Institute, CIBBIM-Nanomedicine, 08035 Barcelona, Spain.ORCID 0000-0001-7178-3290
Nadezda ApostolovaService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0002-4487-2471
Clara Luna-MarcoService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.
Susana Rovira-LlopisService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0002-8476-5128
Miguel MartiDepartment of Pharmacology, University of Valencia, 46003 Valencia, Spain.
Carlos MorillasService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0002-3745-4423
Milagros RochaService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0003-2923-6546
Hermenegildo GarciaInstituto Universitario de Tecnología Química CSIC-UPV, Universidad Politécnica de Valencia, Avenida de los Naranjos s/n, 46022 Valencia, Spain.ORCID 0000-0002-9664-493X
Victor M VictorService of Endocrinology and Nutrition, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region (FISABIO), University Hospital Doctor Peset, 46017 Valencia, Spain.ORCID 0000-0002-3027-3945
Universitat de València · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESInstituto de Tecnología Química · ESVall d'Hebron Institut de Recerca · ES

Funding

Generalitat Valenciana ACIF/2020/370Generalitat Valenciana APOSTD/2020/145Generalitat Valenciana GRISOLIAP/2019/091Generalitat Valenciana PROMETEO/2019/027Government of Spain Maria Zambrano - Ministry of UniversitiesInstituto de Salud Carlos III CIBERehd CB06/04/0071Instituto de Salud Carlos III PI19/00838Instituto de Salud Carlos III PI19/0437
6 · The paper itself

Abstract

Gold-ceria nanoparticles (Au/CeO

Indexed as

atherosclerosisdiabetesgold-ceria nanoparticleinflammationROS

Identifiers

PMID36421483
PMCPMC9686981
OpenAlexW4309738756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.